ArticleAging cell2026
Integrin-Binding Matricellular Protein Fibulin-5 Maintains Epidermal Stem Cell Heterogeneity During Skin Aging.
Article in Aging cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The extracellular matrix (ECM) is crucial in building the extracellular environment and translating extracellular information into biochemical signals that sustain tissue functions. Fibulin-5 (Fbln5) is a multifunctional ECM protein essential for forming elastic fibers and regulating cellular functions by binding to integrins. Although fibulin-5 expression decreases with age in human skin, its functional implications, particularly in epidermal stem cell regulation, remain largely unexplored. Here, we show that the loss of Fbln5 in mice leads to early impairments of epidermal stem cell properties that resemble changes observed during chronological skin aging. Fbln5 deficiency is associated with reduced expression of integrins and other cell junction proteins and decreased YAP activation in epidermal stem cells. Pharmacological inhibition of YAP reduces the fast-cycling stem cell region in mice and downregulates the fast-cycling epidermal stem cell marker SLC1A3 in human primary keratinocytes. At the cellular level, YAP activity and SLC1A3 expression are modulated by cell density, with low-density cultures exhibiting high nuclear YAP and elevated SLC1A3 expression, whereas high-density conditions suppress both. Under high-density conditions, fibulin-5 coating partially restores nuclear YAP localization and increases SLC1A3 expression. Together, these findings suggest that, beyond its structural role in elastic fiber formation, fibulin-5 contributes to the maintenance of epidermal stem cell balance during skin aging by linking extracellular alterations to YAP-dependent intracellular signaling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.